Search Results

You searched for : monotherapy

	European Commission approves Teysuno in metastatic colorectal cancer Latest Corporate news updates; Pharma Feb 3rd 2022... Feb 03
	Innovent and GenFleet announce Exclusive Global License agreement for GFH925 (KRAS G12C Inhibitor) Latest Pharma News update... Sep 03
	ImmixBio and BeiGene to evaluate combination of IMX-110 and Tislelizumab in solid tumors Latest Pharma News Update... Aug 31
	Adagene Announces the Third Clinical Trial Collaboration with Merck to Advance Anti-CD137 Agonist, ADG106 Latest Pharma Update... Aug 23
	Alkermes Receives FDA fast track designation for Nemvaleukin Alfa for the treatment of Mucosal Melanoma FDA News Update... Aug 05
	Bristol Myers Squibb Provides Update on CheckMate -651 Trial Evaluating Opdivo Plus Yervoy Versus EXTREME Regimen as First-Line Treatment for Squamous Cell Carcinoma ... Jul 17
	Immutep receives FDA and IRB approval in the US for Phase IIb TACTI-003 trial in HNSCC Immutep was granted Fast Track designation for efti to treat 1st line HNSCC patients by the US FDA in early April 2021. ... Jul 12
	LYNPARZA (olaparib) Approved in China for the Treatment of Certain Patients with BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer Only PARP Inhibitor to Demonstrate Overall Survival Versus New Hormonal Treatments in BRCA1/2-Mutated Advanced Prostate Cancer... Jun 24
	Koselugo approved in the EU for children with neurofibromatosis type 1 and plexiform neurofibromas First medicine approved in the EU to treat this rare and debilitating genetic condition... Jun 22
	GSK and iTeos Therapeutics announce development and commercialisation collaboration for EOS-448 With this collaboration GSK is uniquely positioned with access to antibodies that synergistically target all three known CD226 checkpoints - TIGIT, CD96 and PVRIG.... Jun 14
	Bristol Myers Squibb announces LAG-3-Blocking antibody Relatlimab and Nivolumab fixed-dose Combination Significantly improves progression-free Survival vs. Opdivo (nivolumab) in patients... May 22
	GSK and Vir Biotechnology starts EMA rolling review of VIR-7831 (sotrovimab) for treatment of COVID-19 GSK's Covid product could be soon in the market after the emergency medical application review... May 11
	Rocheâ€™s Tecentriq approved by European Commission for metastatic non-small cell lung cancer Tecentriq is now the first and only single-agent cancer immunotherapy with three dosing options... May 08
	GSK and Vir Biotechnology requests emergency use authorization to FDA for VIR-7831 for treatment of COVID-19 The FDA EUA submission is based on an interim analysis of efficacy and safety data from the Phase 3 COMET-ICE ... Mar 27
	GSK and Vir Biotechnology requests emergency use authorization to FDA for VIR-7831 for treatment of COVID-19 The FDA EUA submission is based on an interim analysis of efficacy and safety data from the Phase 3 COMET-ICE ... Mar 27
	Intra-Cellular Therapies Applies for FDA Approval of CAPLYTA (lumateperone) CAPLYTA (lumateperone)is indicated for the treatment of Bipolar Depression... Feb 23
	NMPA Approves Toripalimab in patients with recurrent or metastatic Nasopharyngeal Carcinoma Approval comes after Failure of at Least Two Lines of Prior Systemic Therapy... Feb 22
	Compugen expands clinical collaboration agreement with Bristol Myers Squibb Compugen Ltd expands collaboration agreement with Bristol Myers Squibb with phase 1b combination study of COM701 with opdivo C... Feb 22
	BeiGene reports FDA approval for Brukinsa(Zanubrutinib ) Brukisa is indicated for the treatment of adult patients with WaldenstrÃ¶mâ€™s Macroglobulinemia ... Feb 19
	AtraZeneca's Imfinzi approved in the EU for less-frequent, fixed-dose use in unresectable non-small cell lung cancer New option extends dosing from two to four weeks, reducing medical visits and improving patient convenience ... Jan 15
	FDA Grants Priority Review to Merckâ€™s Supplemental Biologics License Application for KEYTRUDA ... Dec 18
	Trastuzumab deruxtecan recommended for approval in the EU by CHMP for HER2-positive metastatic breast cancer The impact of the disease is significant, with breast cancer responsible for more than 137,000 deaths per year.... Dec 14
	BAVENCIO receives positive CHMP opinion for first-line maintenance treatment of locally advanced or metastatic urothelial carcinoma This year US FDA has approved BAVENCIO for the maintenance treatment of patients with locally advanced or metastatic UC... Dec 12
	Merck Receives Positive EU CHMP Opinion for KEYTRUDA as First-Line Treatment for Metastatic Microsatellite Instability ... Dec 11
	Calquence data across four trials reinforces cardiovascular safety profile for chronic lymphocytic leukaemia ... Dec 08
25 Matching result(s) found!

-Advertisements-

Trending Now
	Bharti Singh's Battle with Gallstones: Symptoms, Precautions, and Natural RemediesMay 04, 2024
	Empowering Women's Health: New Mammogram GuidelinesMay 04, 2024
	Rising Temperatures, Rising Risks: Addressing the Challenges of Heat StressMay 04, 2024
	Gynoveda, India's First Ayurveda Fertility Company, Expands Reach with New Clinic in Pune, Set to Open 100 Clinics Across India by 2027May 03, 2024
	Aptus Value Housing Finance India Limited, a leading Housing Finance Company has declared its financial results for the year ended March 31, 2024. FY 24 ResultsMay 03, 2024
	TIPS FOR PREGNANCY CARE DURING SUMMERMay 03, 2024
	The deadly intersection: TB and tobacco smoking co-epidemics in Indonesia Dr TARA SINGH BAM – CNSMay 03, 2024
	Mintoak Expands Global Footprint with Strategic Leadership AppointmentsMay 03, 2024
	The Future of Healthcare: 10 ways Telehealth is Improving Patient Outcomes and Reducing CostsMay 03, 2024
	Understanding the Effects of a Keto Diet on Your Body: A One-Month JourneyMay 03, 2024
	High Blood Pressure in Youth: A Precursor to Severe Heart ConditionsMay 03, 2024
	High Blood Pressure in Youth: A Precursor to Severe Heart ConditionsMay 03, 2024
	Microplastics in Human Brains: Understanding the Emerging Health ConcernMay 03, 2024
	Federal Bank Wraps Up FY 24 With 24% Rise in Profit, highest NII, Maintains Robust Asset QualityMay 02, 2024
	Two Aveksha Day Care Centers for Construction Workers’ Children opened on the occasion of Labour Day May 02, 2024
	AbbVie India and Sightsavers India Collaborate to Raise Awareness on GlaucomaMay 02, 2024
	Whither social justice and decent work for women?May 02, 2024
	Hyderabad's senior anesthesiologist at the L V Prasad Eye Institute, Dr Raja Narsing Rao elected as President of the World Congress of Ophthalmic AnaesthesiaMay 02, 2024
	Navigating Legal Waters: Covishield's Side Effects Prompt Legal Battle from Parents May 02, 2024
	Mumps Resurgence in India: Understanding the Recent Outbreak and Prevention StrategiesMay 02, 2024

Search Results

European Commission approves Teysuno in metastatic colorectal cancer

Innovent and GenFleet announce Exclusive Global License agreement for GFH925 (KRAS G12C Inhibitor)

ImmixBio and BeiGene to evaluate combination of IMX-110 and Tislelizumab in solid tumors

Adagene Announces the Third Clinical Trial Collaboration with Merck to Advance Anti-CD137 Agonist, ADG106

Alkermes Receives FDA fast track designation for Nemvaleukin Alfa for the treatment of Mucosal Melanoma

Bristol Myers Squibb Provides Update on CheckMate -651 Trial Evaluating Opdivo Plus Yervoy Versus EXTREME Regimen as First-Line Treatment for Squamous Cell Carcinoma

Immutep receives FDA and IRB approval in the US for Phase IIb TACTI-003 trial in HNSCC

LYNPARZA (olaparib) Approved in China for the Treatment of Certain Patients with BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer

Koselugo approved in the EU for children with neurofibromatosis type 1 and plexiform neurofibromas

GSK and iTeos Therapeutics announce development and commercialisation collaboration for EOS-448

Bristol Myers Squibb announces LAG-3-Blocking antibody Relatlimab and Nivolumab fixed-dose Combination

GSK and Vir Biotechnology starts EMA rolling review of VIR-7831 (sotrovimab) for treatment of COVID-19

Rocheâ€™s Tecentriq approved by European Commission for metastatic non-small cell lung cancer

GSK and Vir Biotechnology requests emergency use authorization to FDA for VIR-7831 for treatment of COVID-19

GSK and Vir Biotechnology requests emergency use authorization to FDA for VIR-7831 for treatment of COVID-19

Intra-Cellular Therapies Applies for FDA Approval of CAPLYTA (lumateperone)

NMPA Approves Toripalimab in patients with recurrent or metastatic Nasopharyngeal Carcinoma

Compugen expands clinical collaboration agreement with Bristol Myers Squibb

BeiGene reports FDA approval for Brukinsa(Zanubrutinib )

AtraZeneca's Imfinzi approved in the EU for less-frequent, fixed-dose use in unresectable non-small cell lung cancer

FDA Grants Priority Review to Merckâ€™s Supplemental Biologics License Application for KEYTRUDA

Trastuzumab deruxtecan recommended for approval in the EU by CHMP for HER2-positive metastatic breast cancer

BAVENCIO receives positive CHMP opinion for first-line maintenance treatment of locally advanced or metastatic urothelial carcinoma

Merck Receives Positive EU CHMP Opinion for KEYTRUDA as First-Line Treatment for Metastatic Microsatellite Instability

Calquence data across four trials reinforces cardiovascular safety profile for chronic lymphocytic leukaemia

Trending Now